Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00797004 · ClinicalTrials.gov registry record

Olfactory Dysfunction of Rhinosinusitis

A clinical trial, sponsored by Greg Davis.

Completed
Registry status
23
Enrollment target

NCT00797004 is a clinical trial that has completed, run by Greg Davis. The registered enrollment target is 23 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00797004 has completed, sponsored by Greg Davis.

COMPLETED
Registry status
23 participants
Enrollment target

Study Summary

The purpose of this research is to improve understanding of the molecular and functional properties of the human olfactory system. The specific aims are: * to determine the location of AC3 and Golf proteins in the human olfactory epithelium from freshly harvested nasal/sinus tissue of surgical patients * to perform objective functional studies on fresh human nasal/sinus tissue using an electro-olfactogram (EOG) whic measures the electrical activity of olfactory sensory neurons in fresh biopsied tissue in response to odor or pheromone stimulation. An organotypic culture system for human tissue has been established to optimize the electrical signal acquisition. * to correlate the AC3 and Golf expression profiles with pre-operative testing of human olfactory function * to correlate the EOG findings with pre-operative testing of human olfactory function. * to systematically evaluate the role of individual intranasal agents on olfaction to further optimize the electrical signal acquisition from olfactory tissue.

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2008-11
Est. Completion 2010-09

Sponsor

Greg Davis

4 total trials

What the Registry Record Tells You About NCT00797004

The ClinicalTrials.gov registry entry for NCT00797004 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Greg Davis, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00797004 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00797004 about?

NCT00797004 is a clinical study titled "Olfactory Dysfunction of Rhinosinusitis". The purpose of this research is to improve understanding of the molecular and functional properties of the human olfactory system. The specific aims are: * to determine the location of AC3 and Golf proteins in the human olfactory epithelium from freshly harvested nasal/sinus tissue of surgical pat...

What is the current status of trial NCT00797004?

This trial is currently completed. The enrollment target is 23 participants. The study started on 2008-11. Estimated completion is 2010-09.

Who is sponsoring clinical trial NCT00797004?

This trial is sponsored by Greg Davis, which has 4 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.